Exact Therapeutics AS (EXTX.OL) Stock Price

Exact Therapeutics AS Price

CLOSED
0.70
​
Market closed

Exact Therapeutics AS stock price

Access this data via the Eulerpool API

Exact Therapeutics AS business model & stock analysis

EXACT Therapeutics AS is a clinical stage biopharmaceutical company, which engages in the research and development of novel platform for ultrasound mediated therapeutic amplification. The company is headquartered in Oslo, Oslo. The company went IPO on 2020-07-14. ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The firm's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. The company is done through harnessing the power of ultrasound in combination with ACT formulation.

Frequently asked questions about Exact Therapeutics AS

Converted at the current exchange rate, the Exact Therapeutics AS share trades at 0.07 EUR (0.70 NOK).

The revenue cannot currently be calculated for Exact Therapeutics AS.

The profit cannot currently be calculated for Exact Therapeutics AS.

The P/E ratio cannot be calculated for Exact Therapeutics AS at the moment.

The P/S cannot be calculated for Exact Therapeutics AS currently.

The Eulerpool Quality Score for Exact Therapeutics AS is 2/10.

The ISIN of Exact Therapeutics AS is NO0010852213. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Exact Therapeutics AS is A2P9GM. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Exact Therapeutics AS is EXTX.OL. The ticker symbol is used to trade Exact Therapeutics AS shares on the stock exchange.

Fair ValueTerminal
0.59 NOK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website exact-tx.com
Country
Norway
Currency
NOK
Initial public offering
Jul 14, 2020
ISIN
NO0010852213
Cusip
R6S64N118
Market capitalization
44.28 M NOKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.44
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-283.21 %
Last updated Oct 11, 2026, 9:58 PM

Exact Therapeutics AS Peer Group

Exact Therapeutics AS FIGI

EXTX:NO · BBG00W0H5K01EXTXMNOK:EP · BBG00W0JLW12EXTXMNOK:EZ · BBG00W0JLW30EXTXMNOK:XS · BBG00W0JLW49EXTXMNOK:X2 · BBG00W0JLW58EXTXMNOK:XH · BBG00W0JLW76EXTXMNOK:XF · BBG00W0JLW94EXTXMNOK:XE · BBG00W0JLWC0EXTXMNOK:XJ · BBG00W0JLWD9EXTXMNOK:XL · BBG00W0JLWF7EXTXMNOK:XG · BBG00W0JLWG6EXTXMNOK:XO · BBG00W0JLWH5